This guide is provided strictly for educational and informational purposes and does not constitute medical advice, diagnosis, or clinical treatment. Always consult a qualified healthcare professional regarding any medical condition, biomarker interpretation, or treatment plan.
Contents
A guide without cut-offs
Almost everything written about iron deficiency is organised around a cut-off, with deficiency below it and normal above. That framing is why so many people are told they are normal while they are still unwell.
Reference ranges differ between laboratories and between health systems, so the same blood can be labelled differently depending on who processes it. Those ranges describe the spread of a sampled population and say nothing about when a person becomes symptomatic. And a single value carries no direction: it cannot tell you whether you are falling, holding or recovering.
This guide teaches the relationships: what each marker represents, how they move against one another, and what a sequence of results over time is telling you. If you want the threshold conversation, my articles on ferritin and the reference range and iron deficiency without anaemia address it directly, and they are the place to start if you are holding a result right now.
Iron status as a continuum
Iron balance sits on a spectrum that runs from overload at one end to severe deficiency at the other. Everyone occupies a position on it, and that position moves. Health is where you sit and which way you are travelling.
A fixed line forces a binary answer onto a continuous quantity. Two people with identical results can have entirely different clinical pictures depending on where each of them was six months ago, what their demands are, and what their own baseline looks like. The rest of this guide rests on evaluating iron status against the individual.
The iron balance equation
Whatever is happening to your iron, it resolves to four mechanisms. Anything that lowers iron status does so through at least one of them, and effective management starts by identifying which one is operating.
- Increased loss. Menstrual blood loss, and particularly heavy menstrual bleeding, has a greater influence on iron stores in premenopausal women than dietary intake. Blood donation counts. So do exercise-related losses through sweat and foot-strike haemolysis.
- Increased demand. Adolescent growth, pregnancy, and sustained high endurance training loads all raise the amount of iron the body needs to hold its position.
- Decreased intake. Meat-restricted diets, and low total energy availability, where overall food intake is simply not enough to carry the micronutrients with it.
- Decreased absorption. Dietary inhibitors such as the tannins in tea and coffee, and calcium taken alongside iron. The absence of enhancers such as vitamin C. And gastrointestinal malabsorption, which is a medical issue in its own right.
The progression
Deficiency moves through stages, and the marker most clinical practice screens on is the one that changes last.
Stage 1, depleted stores. Storage iron falls while red cell production carries on unaffected. The body is drawing down its reserve.
Stage 2, iron-deficient erythropoiesis. Transport saturation drops. There is no longer enough iron reaching the bone marrow to make red cells at the usual rate and quality.
Stage 3, overt anaemia. Oxygen-carrying capacity falls past the point the body can compensate for. This is the stage a haemoglobin test is designed to catch.
Iron deficiency without anaemia
Stages 1 and 2 have a name: iron deficiency without anaemia, or IDNA. It describes active tissue-level deficiency, with symptoms, occurring while haemoglobin sits inside its normal reference range.
A screening approach built on haemoglobin alone will return a normal result throughout stages 1 and 2. The person is symptomatic, the deficiency is real and treatable, and the test says nothing is wrong. Every month spent in that state is a month of symptoms, and the depletion generally continues while it lasts.
If fatigue is being investigated and only haemoglobin has been measured, the storage and transport markers are still to be checked. They are what distinguish stages 1 and 2 from normal iron status.
Symptoms, functional impact and individual risk
Iron sits at the centre of oxygen transport, cellular energy production, and several enzyme systems in the brain. That is why the symptom picture is broader than the word anaemia suggests, and why it is so often attributed to something else.
The symptom profile
Iron deficiency can cause symptoms with anaemia, without anaemia, or none at all. Being asymptomatic does not mean iron status is fine.
Common symptoms and signs are fatigue and lethargy, reduced concentration, dizziness, tinnitus, pallor and headache.
In susceptible people, iron deficiency promotes restless legs syndrome.
Other presentations include alopecia, dry hair or skin, koilonychia (spoon-shaped nails), and atrophic glossitis, a smooth and inflamed tongue.
Pica is the compulsive eating of things that are not food: ice, soil or clay, or raw ingredients such as uncooked rice. It sounds unusual enough that people do not mention it, so it is worth asking about.
Iron deficiency worsens the prognosis of heart failure and ischaemic heart disease, and severe iron deficiency anaemia can cause haemodynamic instability. Even when it produces no symptoms at all, iron deficiency can leave function below where it should be.
Symptom profile per Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. The Lancet, published online 4 December 2020. doi:10.1016/S0140-6736(20)32594-0
Most of this list can be explained away. Tiredness gets attributed to work, to sleep, to stress, to age, to parenting. Each of those explanations is plausible on its own, and collectively they are how a treatable deficiency goes unexamined for years.
Groups at higher risk
- Premenopausal people, and particularly anyone with heavy menstrual bleeding.
- Pregnant and postpartum people, where demand rises sharply and stays raised.
- Endurance athletes and consistently active populations, through the combination of loss and demand.
- Anyone with dietary restriction, or with a known or suspected gastrointestinal absorption problem.
Sitting in one of these groups does not mean you are deficient, and sitting outside all of them does not mean you are not. Elevated risk lowers the threshold for investigating and raises how seriously an unexplained symptom pattern should be taken.
The Iron Risk Check
A short set of questions about the risk factors and symptoms linked to iron deficiency. Two minutes, free, and it gives you a plain-language summary you can take to your GP.
Could you be iron deficient?The biomarkers, and how they relate to each other
Laboratory data interpretation must always be performed in partnership with a qualified clinician. What follows explains what the markers represent and how they move together. It is not a substitute for having them read by someone who can examine you.
The iron studies
Serum ferritin is the biscuit tin. It is the storage protein, and it tells you what is in reserve. It is the most sensitive early marker of depletion for a simple reason: the body empties the tin before it lets anything else change.
Transferrin is the delivery fleet. It is the protein that carries iron through the blood to the tissues that need it. When iron is scarce the body builds more trucks, trying to capture whatever is available. When iron is plentiful it builds fewer. Transferrin therefore moves in the opposite direction to iron status, which surprises people the first time they see it.
Transferrin saturation, usually written TSAT, is the proportion of those trucks currently carrying a load. It is the closest thing in a standard panel to a measure of how much iron is reaching tissue. A large fleet running mostly empty is a specific and informative picture.
Serum iron is the iron circulating at the moment of the draw. It moves through the day, and it responds to a recent meal or supplement, so it carries far less meaning on its own than the other three.
The full blood count
Haemoglobin is the oxygen-carrying protein inside red cells, with iron at its centre. Red cell count and haematocrit describe how many red cells there are and what proportion of blood volume they occupy.
Mean corpuscular volume, or MCV, is the average size of a red cell. Iron deficiency produces smaller cells, so MCV falls. Mean corpuscular haemoglobin and its concentration describe how much haemoglobin each cell carries. Haemoglobin concentration and haematocrit are sensitive to plasma volume: dehydration contracts plasma and inflates them, which is one reason the conditions of the blood draw matter.
Red cell distribution width, or RDW, measures how variable red cell size is. It rises in iron deficiency because older normal-sized cells and newly made smaller ones are circulating at the same time.
Platelets can rise in iron deficiency. On their own they mean little; alongside the rest of the picture they are another piece of corroboration.
Marker patterns
No single marker settles the question. The information is in the combinations, because different conditions produce different patterns across the panel.
| Pattern | What it usually indicates | Why |
|---|---|---|
| Ferritin low, haemoglobin normal | Iron deficiency without anaemia | Storage is drained while red cell production is still compensated. Symptoms can be present throughout. |
| Ferritin low, haemoglobin low | Iron deficiency anaemia | The reserve is gone and oxygen-carrying capacity has fallen with it. |
| Ferritin high or normal, haemoglobin low, CRP raised | Functional iron deficiency, or anaemia of inflammation | Ferritin is an acute phase protein. Inflammation drives iron into storage and holds it there, away from red cell production. There may be plenty of iron in the body and not enough reaching the marrow. |
| Ferritin normal, MCV raised | Look beyond iron | Larger rather than smaller cells point towards vitamin B12 or folate rather than iron. |
A raised ferritin with an inflammatory marker alongside it can look reassuring on a report and mean the opposite. Reading ferritin without C-reactive protein (CRP) is how functional iron deficiency gets missed.
Your own trajectory
The most useful comparison is against yourself, six months ago.
For that comparison to mean anything, the conditions have to be consistent: a morning draw, fasted, rested beforehand, and where relevant at a comparable point in the menstrual cycle. Iron markers move with all of these, and a result taken under different conditions is not comparable to the one before it. Two results collected carelessly can differ by more than a real change would.
Read the direction against what has changed in your life. A shift in contraception, a rise in training load, a change in diet, a pregnancy, a period of heavier bleeding: these are the things that move a trajectory, and pairing the trend with the cause is what turns a set of numbers into a decision.
Your results over time, the conditions each was taken under, and the symptom pattern alongside them. A trend with context is the format a clinician can act on.
Repletion, matched to the mechanism
What works to restore iron depends on which of the four mechanisms is operating, how far depletion has progressed, and what a person can tolerate and sustain.
Treatment that ignores the mechanism fails predictably. Supplementing someone whose losses exceed what they can absorb will not hold. Adding iron to a diet when the problem is malabsorption does not address the problem. Dietary change a person will not maintain has no effect.
Repletion for a vegan or vegetarian is a technical problem with technical answers, worked within the diet they have chosen.
Diet and absorption
Iron from animal sources, haem iron, is absorbed more readily than the non-haem iron in plants. That is a difference in efficiency, and non-haem absorption is strongly modifiable.
Vitamin C taken with an iron source meaningfully improves non-haem absorption, so take the two together.
Tannins in tea and coffee, calcium, and phytates all reduce absorption. Taking them at a different time from iron-containing meals or supplements avoids that interference, and the morning coffee stays.
Oral iron
Formulations differ. Ferrous salts are the long-standing option and the cheapest. Other formulations, such as iron polymaltose, cost more and absorb differently.
Taking iron raises hepcidin, the hormone that regulates absorption, and that rise blunts uptake for a period afterwards. Dosing on alternate days works with that rhythm. The practical result is better absorption per dose and, in one small trial, fewer gastrointestinal side effects.
The most effective supplement is the one that gets taken for the whole course, and gastrointestinal upset is a common reason courses are abandoned before they have done anything.
Intravenous iron
Intravenous iron is indicated in specific situations: intolerance of oral iron, malabsorption, ongoing blood loss that outpaces oral repletion, or a clinical need to correct quickly. Modern formulations, such as ferric carboxymaltose and ferric derisomaltose, allow substantial replacement in few visits.
A corrected ferritin does not guarantee that everything else follows: in the review of intravenous iron I led, ferritin rose substantially and fatigue improved, while quality of life showed no overall difference from placebo, on low-quality evidence. Knowing that in advance stops a normal recovery being mistaken for a failed treatment.
Long-term monitoring
Most of the value lies in holding the correction, and that is where most plans stop.
Retesting
A reasonable pattern is to retest roughly six to twelve weeks after treatment, and then every three to six months while stability is established, with a view over one to two years. The purpose is to see whether ferritin has stabilised and transferrin saturation has recovered.
Symptoms alone are an unreliable endpoint. They fluctuate for many reasons, and a short-term dip in fatigue can be mistaken for repletion when stores are still low.
Resolving the cause
If the mechanism driving loss is still operating, the deficiency will return.
That means heavy menstrual bleeding needs to be evaluated as a clinical issue, with gynaecological input where it is warranted. It means unexplained iron deficiency in men and postmenopausal women warrants gastrointestinal investigation. And it means the plan has to survive the changes ahead of it: pregnancy, a rise in training, a dietary shift, perimenopause. Each of those moves the balance, and a trajectory that was stable under one set of demands will not necessarily hold under the next.
The shape of it
This guide describes one loop, repeated: identify which mechanism is operating, match the repletion to it, confirm the recovery with a trajectory, address the cause so the correction holds, and watch it across the life stages that will test it.
Running it means knowing what the markers represent, reading them as a system, and keeping a record of your own over time.
The free discovery call
A free 30-minute discovery call to talk through your fatigue, your bloods, and whether one-to-one sessions are the right next step. No obligation, and most people leave knowing what to test and what to ask.
Book a discovery callSources
- Camaschella C. Iron-deficiency anemia. New England Journal of Medicine 2015;372(19):1832-1843. doi:10.1056/NEJMra1401038Used for: iron stores falling before anaemia develops; ferritin as the most sensitive marker; the causes behind the four mechanisms (menstrual loss, blood donation, adolescent growth, pregnancy, vegetarian and vegan diets, malabsorption); and the situations for intravenous iron.
- Dugan C, Cabolis K, Miles LF, Richards T. Systematic review and meta-analysis of intravenous iron therapy for adults with non-anaemic iron deficiency: an abridged Cochrane review. Journal of Cachexia, Sarcopenia and Muscle 2022;13(6):2637-2649. doi:10.1002/jcsm.13114Used for: intravenous iron raising ferritin and improving fatigue, with no overall change in quality of life.
- Dugan C, Peeling P, Davies A, et al. The relationship between menorrhagia, iron deficiency, and anaemia in recreationally active females: an exploratory population based screening study. Journal of Science and Medicine in Sport 2024;27(7):437-450. doi:10.1016/j.jsams.2024.04.012Used for: heavy menstrual bleeding and its association with a self-reported history of iron deficiency and anaemia in active women.
- Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 2015;126(17):1981-1989. doi:10.1182/blood-2015-05-642223Used for: a dose of iron raises hepcidin, which blunts absorption of the next dose.
- Pasricha SR, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. The Lancet 2021;397(10270):233-248. doi:10.1016/S0140-6736(20)32594-0Used for: the symptom profile, restless legs, pica and heart disease; menstrual loss in premenopausal women; exercise losses through sweat and haemolysis; iron-deficient red cell production before anaemia; smaller red cells and a wider red cell distribution width; transferrin saturation and serum iron; haem and non-haem absorption, vitamin C, tannins, calcium and phytates; ferritin as an acute phase protein, read alongside C-reactive protein; gastrointestinal blood loss in men and postmenopausal women; ferrous salts, iron polymaltose and intravenous formulations.
- Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. The Lancet Haematology 2017;4(11):e524-e533. doi:10.1016/S2352-3026(17)30182-5Used for: alternate-day dosing and absorption per dose.
- Tolkien Z, Stecher L, Mander AP, et al. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One 2015;10(2):e0117383. doi:10.1371/journal.pone.0117383Used for: gastrointestinal side effects of ferrous salts, and why courses of oral iron are abandoned.